dronabinol has been researched along with Cancer of Colon in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez-Fuentes, J; Durán-Lobato, M; Fernández-Arévalo, M; Martín-Banderas, L | 1 |
| Čatalinac, M; Jurič, A; Karačonji, IB; Katić, A; Kozina, G; Micek, V; Neuberg, M; Vrdoljak, AL; Žunec, S | 1 |
| Gustafsson, SB; Jacobsson, SO; Jonsson, M; Lindgren, T | 1 |
| Babu, D; Kim, JA; Kim, JM; Kwak, MK; Kwon, TK; Lee, YR; Park, MA; Thapa, D | 1 |
4 other study(ies) available for dronabinol and Cancer of Colon
| Article | Year |
|---|---|
Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization.
Topics: Antineoplastic Agents; Caco-2 Cells; Capsules; Cell Survival; Colonic Neoplasms; Dronabinol; Drug Liberation; Humans; Ligands; Nanoparticle Drug Delivery System; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cannabinoid; Receptors, Transferrin; Transferrin | 2022 |
Effects of concomitant use of THC and irinotecan on tumour growth and biochemical markers in a syngeneic mouse model of colon cancer.
Topics: Animals; Biomarkers; Colonic Neoplasms; Dronabinol; Humans; Irinotecan; Male; Mice; Quality of Life | 2023 |
Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antioxidants; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclic AMP; Dronabinol; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Fatty Acids, Unsaturated; Fluorouracil; Humans; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Piperidines; Pyrazoles; Receptors, Cannabinoid; Thymidine; Tumor Cells, Cultured | 2009 |
Induction of p53-independent apoptosis by a novel synthetic hexahydrocannabinol analog is mediated via Sp1-dependent NSAID-activated gene-1 in colon cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Benzothiazoles; Colonic Neoplasms; Dronabinol; Genes, p53; HCT116 Cells; HT29 Cells; Humans; Protein Kinases; Sulindac; Toluene; Tumor Suppressor Protein p53 | 2010 |